Insider transactions

Ernest Mario

CIK 1180469 · last filed 2024-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$3.92M
Companies
15
Total Filings
301
Lifetime Open-Market Net
-$44.39M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

CELGZ price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
20 FAIRMOUNT AVENUE
P.O. BOX 445
CHATHAM, NJ 07928
Related Filers
CELGENE CORP /DE/ — 64 joint filings, latest 2019-11-22
PHARMACEUTICAL PRODUCT DEVELOPMENT INC — 55 joint filings, latest 2011-12-06
BOSTON SCIENTIFIC CORP — 36 joint filings, latest 2015-11-17
MAXYGEN INC — 12 joint filings, latest 2012-06-07
MILLENNIUM PHARMACEUTICALS INC — 1 joint filings, latest 2002-10-18
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SOLENO THERAPEUTICS INC (SLNO) Delisted Director 214,855 $53.01 $11.39M $0 20 2024-06-10
HYPERION DEFI, INC. (EYEN) Delisted Director 4,784 $15.82 $75.7K $1.19M 8 2021-11-22
Kindred Biosciences, Inc. (KIN) Delisted Director 125,000 $9.25 $1.16M $387.0K 14 2021-01-22
CELGENE CORP /DE/ (CELGZ) Delisted Director 0 — — -$26.01M 51 2019-11-22
SOLENO THERAPEUTICS INC (SLNOW) Delisted Director 471,218 — — $0 12 2019-06-12
TNXP Director 0 $5.30 $0 $1.03M 30 2018-06-27
CHIMERIX INC (CMRX) Delisted Director 121,072 $8.54 $1.03M $1.22M 36 2018-05-21
SOLENO THERAPEUTICS INC (CAPNW) Delisted Director 1,795,929 — — $0 2 2017-05-09
SOLENO THERAPEUTICS INC (CAPN.W) Delisted Director 1,789,678 — — $522.7K 20 2016-10-11
BSX Director 86,032 $45.58 $3.92M -$4.09M 47 2015-11-17
XENOPORT INC (XNPT) Delisted Director 88,750 — — $194.8K 6 2015-05-21
VIVUS INC (VVUS) Delisted Director 8,112 — — $758.9K 5 2013-05-30
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted Director 0 — — -$20.28M 31 2011-12-06
CELGENE CORP /DE/ (CELG) Delisted Director 46,370 — — $687.4K 9 2010-06-18
Alexza Pharmaceuticals Inc. (ALXA) Delisted Director 1,818 — — $0 2 2007-07-26

Recent Filings · Page 2 of 31

301 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-11-02 SOLENO THERAPEUTICS INC (SLNO) Delisted Grant (A) +26,888 $0 EDGAR
2021-08-03 SOLENO THERAPEUTICS INC (SLNO) Delisted Grant (A) +21,978 $20.0K EDGAR
2021-06-04 SOLENO THERAPEUTICS INC (SLNO) Delisted Grant (A) — $0 EDGAR
2021-05-04 SOLENO THERAPEUTICS INC (SLNO) Delisted Grant (A) +16,529 $20.0K EDGAR
2021-02-02 SOLENO THERAPEUTICS INC (SLNO) Delisted Grant (A) +8,928 $0 EDGAR
2021-01-22 Kindred Biosciences, Inc. (KIN) Delisted Grant (A) — $0 EDGAR
2021-01-19 HYPERION DEFI, INC. (EYEN) Delisted Exer (X) +41,216 $93.6K EDGAR
2021-01-12 SOLENO THERAPEUTICS INC (SLNO) Delisted Grant (A) — $0 EDGAR
2020-11-03 SOLENO THERAPEUTICS INC (SLNO) Delisted Grant (A) +10,057 $17.5K EDGAR
2020-09-15 HYPERION DEFI, INC. (EYEN) Delisted Grant (A) +7,288 $0 EDGAR
Showing 11–20 of 301
Page 2 of 31
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.